Home » Topics » Regulatory

Regulatory
RSS

Zometa will receive priority review for treatment of bone metastases

Oct. 24, 2001

Clinical trials of Remicade for congestive heart failure put on hold

Oct. 24, 2001

FDA grants expedited approval for Protonix I.V. in Zollinger-Ellison syndrome Rx

Oct. 24, 2001

Gleevec submitted for FDA review in gastrointestinal tumors

Oct. 24, 2001

Approval of Xeloda for treatment of breast cancer recommended in E.U.

Oct. 23, 2001

CPMP issues positive opinion regarding MabThera for treatment of aggressive NHL

Oct. 22, 2001

Once-daily Adderall XR approved by FDA for ADHD; registration trial discussed at CNS meeting

Oct. 19, 2001

First approval granted for Spiriva in The Netherlands for treatment of COPD

Oct. 19, 2001

FDA advisory committee decision on Diovan for heart failure indication

Oct. 19, 2001

FDA clears use of Allergan's Tazorac cream for treatment of acne

Oct. 18, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 14, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026